Page last updated: 2024-08-26

diosgenin and palbociclib

diosgenin has been researched along with palbociclib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cai, E; Chen, R; Fu, H; Ke, K; Li, X; Shen, J; Shen, Z; Shi, X; Song, N; Wan, W; Wang, J; Xie, X; Zhang, Q; Zhang, R; Zhang, Z; Zuo, A1

Other Studies

1 other study(ies) available for diosgenin and palbociclib

ArticleYear
Polyphyllin I, a lethal partner of Palbociclib, suppresses non-small cell lung cancer through activation of p21/CDK2/Rb pathway
    Cell cycle (Georgetown, Tex.), 2021, Volume: 20, Issue:23

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Diosgenin; Humans; Lung Neoplasms; Piperazines; Pyridines; Retinoblastoma Protein; Signal Transduction

2021